Alnylam Pharmaceuticals
Associate Director: Health System Medical Outcomes Science Liaison-Mid-Atlantic
Alnylam Pharmaceuticals, Cambridge, Massachusetts, us, 02140
Overview:Alnylam is seeking a Medical Outcomes Science Liaison (MOSL) to join a high performing customer facing team in US Medical Affairs. The successful candidate will leverage their experience and expertise of the US healthcare landscape to maintain best-in-class scientific presence as "trusted advisors" to key decision makers focused on value and access in the United States healthcare ecosystem, specifically US Health Systems (IDNs), Specialty Pharmacies, and Group Purchasing Organizations. This is
not
a Payer facing role.Only candidates that live in the Mid-Atlantic will be considered for this territory.This position will report to the Director of the IDN MOSL team.Key Responsibilities:Perform with clear accountability and urgency for achieving results.Possess a "one team, one goal" mindset and ways of working through close collaboration with key cross-functional partners. Be a
"Trusted Medical Advisor"
for all partners in their territories.Engage and build relationships with IDNs and other healthcare systems.Engage in scientific exchange to understand customer data needs, gather feedback and scientific insights that may identify data to support the value proposition of the Alnylam portfolio.In collaboration with the Strategic Account Lead (SAL), develop account specific strategic plans of action, including a detailed assessment of key influencers and decision makers within each account.Collect and share insights and evidence gaps that help to inform the Value, Evidence, and Strategy (VESt) Team to advance data generation that is meaningful to key decision makers.Identify potential scientific research collaboration opportunities, including real-world evidence generation, by leveraging internal stakeholders (Medical Affairs, Value and Access, VESt) to address evidence needs to support Alnylam's scientific objectives.Support regional and national IDN / healthcare systems congresses as needed.Have a thorough understanding of the Pharmaceutical Industries' compliance requirements along with applicable PhRMA Codes, OIG guidelines, FDA related laws, regulations, and Alnylam's policies.Qualifications:5+ years Medical Affairs (pharmaceutical/biotech industry) experience. Prior field-based experience working directly with Health Systems is highly preferred.Advanced degree in life sciences in one or more of the following: MD, DO, PharmD, PhD. Relevant residency, HEOR Fellowship, MS, MBA or MPH is a plus.Therapeutic Area knowledge and experience in rare diseases is preferred.Demonstrated understanding of pharmacoeconomic and health outcomes research principles is strongly preferred.Solid working knowledge of the US healthcare ecosystems.Possess a willingness and ability to work hands-on and with a sense of urgency, in a fast-paced, scientific, entrepreneurial environment.Solid working knowledge of regulatory and compliance environment.Professional written and verbal communication skills with the ability to effectively present to and engage with a wide range of audiences.Computer proficiency in Excel, Word, PowerPoint, and Adobe.Ability to travel up to 75%.About Alnylam:
Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.Our culture:
Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.
#J-18808-Ljbffr
not
a Payer facing role.Only candidates that live in the Mid-Atlantic will be considered for this territory.This position will report to the Director of the IDN MOSL team.Key Responsibilities:Perform with clear accountability and urgency for achieving results.Possess a "one team, one goal" mindset and ways of working through close collaboration with key cross-functional partners. Be a
"Trusted Medical Advisor"
for all partners in their territories.Engage and build relationships with IDNs and other healthcare systems.Engage in scientific exchange to understand customer data needs, gather feedback and scientific insights that may identify data to support the value proposition of the Alnylam portfolio.In collaboration with the Strategic Account Lead (SAL), develop account specific strategic plans of action, including a detailed assessment of key influencers and decision makers within each account.Collect and share insights and evidence gaps that help to inform the Value, Evidence, and Strategy (VESt) Team to advance data generation that is meaningful to key decision makers.Identify potential scientific research collaboration opportunities, including real-world evidence generation, by leveraging internal stakeholders (Medical Affairs, Value and Access, VESt) to address evidence needs to support Alnylam's scientific objectives.Support regional and national IDN / healthcare systems congresses as needed.Have a thorough understanding of the Pharmaceutical Industries' compliance requirements along with applicable PhRMA Codes, OIG guidelines, FDA related laws, regulations, and Alnylam's policies.Qualifications:5+ years Medical Affairs (pharmaceutical/biotech industry) experience. Prior field-based experience working directly with Health Systems is highly preferred.Advanced degree in life sciences in one or more of the following: MD, DO, PharmD, PhD. Relevant residency, HEOR Fellowship, MS, MBA or MPH is a plus.Therapeutic Area knowledge and experience in rare diseases is preferred.Demonstrated understanding of pharmacoeconomic and health outcomes research principles is strongly preferred.Solid working knowledge of the US healthcare ecosystems.Possess a willingness and ability to work hands-on and with a sense of urgency, in a fast-paced, scientific, entrepreneurial environment.Solid working knowledge of regulatory and compliance environment.Professional written and verbal communication skills with the ability to effectively present to and engage with a wide range of audiences.Computer proficiency in Excel, Word, PowerPoint, and Adobe.Ability to travel up to 75%.About Alnylam:
Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.Our culture:
Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.
#J-18808-Ljbffr